Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 20,222 | 890 | 22,086 | 22,492 | 45,540 |
| Cost of Goods | 9,173 | 2,695 | 9,960 | 12,118 | 21,352 |
| Gross Profit | 11,049 | -1,805 | 12,126 | 10,374 | 24,188 |
| Operating Expenses | 38,192 | 9,233 | 39,785 | 40,753 | 84,722 |
| Operating Income | -26,970 | -10,343 | -26,699 | -30,261 | -60,182 |
| Interest Expense | 0 | 572 | 853 | 858 | 1,033 |
| Other Income | 3,481 | -247 | 5,751 | 5,714 | 29,186 |
| Pre-tax Income | -23,489 | -11,162 | -21,801 | -25,405 | -32,029 |
| Income Tax | -119 | 257 | 118 | 39 | 128 |
| Net Income Continuous | -23,370 | -11,419 | -21,919 | -25,444 | -32,157 |
| Net Income Discontinuous | -2,663 | -22,653 | -5,019 | -20,274 | N/A |
| Net Income | $-26,033 | $-34,072 | $-26,938 | $-45,718 | $-32,157 |
| EPS Basic Total Ops | -0.07 | -0.06 | -0.07 | -0.12 | -0.27 |
| EPS Basic Continuous Ops | -0.06 | -0.15 | -0.06 | -0.07 | -0.11 |
| EPS Basic Discontinuous Ops | -0.01 | -0.08 | -0.01 | -0.05 | N/A |
| EPS Diluted Total Ops | -0.07 | -0.06 | -0.07 | -0.12 | -0.27 |
| EPS Diluted Continuous Ops | -0.06 | -0.15 | -0.06 | -0.07 | -0.11 |
| EPS Diluted Discontinuous Ops | -0.01 | -0.08 | -0.01 | -0.05 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.06 | -0.07 | -0.06 | N/A | N/A |
| EBITDA(a) | $-23,640 | $-7,522 | $-24,600 | $-28,289 | $-57,648 |